Release
📈 Stocks
AbbVie and Genmab Report Positive Phase 3 Results for Epcoritamab in DLBCL
(just now)
AbbVie and Genmab shares gain as the EPCORE DLBCL-2 trial demonstrates superior progression-free survival for frontline lymphoma patients using their bispecific antibody…